Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and Imprime PGG in metastatic NSCLC
NCT03003468Phase 2Completed
- Start
- Jul 2017
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of odetiglucan in non-small cell lung cancer (NSCLC). Started Jul 2017; status: completed.
02
Drugs
odetiglucan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03003468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003468.